Literature DB >> 322438

Human hepatic blood flow and its relation to systemic circulation during intravenous infusion of lidocaine.

L Wiklund.   

Abstract

Twelve healthy young volunteers were studied before and during intravenous administration of lidocaine at a dose rate of 2 or 4 mg/min. Five additional volunteers, who did not receive lidocaine solution but were given the same amount of physiological saline, were studied in the same manner. Heart rate, cardiac output, mean arterial blood pressure, mean right atrial blood pressure, estimated hepatic blood flow and plasma concentration of lidocaine were measured repeatedly. The results showed an increase in heart rate, cardiac output and mean arterial blood pressure, the latter two variables in relation to the plasma concentration of lidocaine. The estimated hepatic blood flow increased, partly as a result of the reduction of splanchnic vascular resistance and partly due to the stimulation of cardiac output. The decrease in splanchnic vascular resistance was proportional to the plasma concentration of lidocaine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322438     DOI: 10.1111/j.1399-6576.1977.tb01204.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

Review 1.  Clinical pharmacokinetics of local anaesthetics.

Authors:  G T Tucker; L E Mather
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

2.  Hepatic clearance of local anesthetics in man.

Authors:  G T Tucker; L Wiklund; A Berlin-Wahlen; L E Mather
Journal:  J Pharmacokinet Biopharm       Date:  1977-04

Review 3.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

4.  Effect of lignocaine on arginine-vasopressin plasma levels: baseline or induced by frusemide.

Authors:  L Gariépy; P Larose; B Bailey; P du Souich
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

5.  Disopyramide and lignocaine. A comparison of cardiac effects using echocardiography.

Authors:  M A Martin; N D Bax; G T Tucker; J W Ward
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

6.  Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.